Preparation and functional analysis of recombinant protein transduction domain-metallothionein fusion proteins

Biochimie

Volumn 92, Issue 8, 2010, Pages 964-970

  Lim, Kwang Suk ^a   Won, Young Wook ^a   Park, Yong Soo ^a   Kim, Yong Hee ^a  

^a Hanyang University   (South Korea)

Author keywords

Anti oxidant and anti apoptotic agent; Diabetes and diabetic complication; Hypoxia; Protein transduction domain Metallothionein fusion protein; Zn Metallothionein clusters

Indexed keywords

11 ARGININE METALLOTHIONEIN; AMINO ACID; ARGININE; BACTERIAL VECTOR; CELL PENETRATING PEPTIDE; CELL PROTEIN; COBALT CHLORIDE; CYSTEINE; HYBRID PROTEIN; METALLOTHIONEIN; PROTEIN TRANSDUCTION DOMAIN; REACTIVE OXYGEN METABOLITE; TAT METALLOTHIONEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; ZINC; ZINC METALLOTHIONEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; EXPRESSION VECTOR; GENE CLUSTER; GENE FUSION; GENETIC TRANSDUCTION; GLUCOLIPOTOXICITY; HEART MUSCLE CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERGLYCEMIA; HYPOXIA; INTRACELLULAR TRANSPORT; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN TRANSPORT; RAT;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; METALLOTHIONEIN; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77954657763     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.04.005     Document Type: Article

References (33)

1. Tabata Y., Ikada Y. Protein release from gelatin matrices. Advanced Drug Delivery Reviews 1998, 31:287-301.
2. Manning M., Patel K., Borchardt R. Stability of protein pharmaceuticals. Pharmaceutical Research 1989, 6:903-918.
3. Wadia J., Dowdy S. Modulation of cellular function by TAT mediated transduction of full length proteins. Current Protein and Peptide Science 2003, 4:97-104.
4. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. Journal of Biological Chemistry 2005, 280:15300-15306.
5. Wender P., Mitchell D., Pattabiraman K., Pelkey E., Steinman L., Rothbard J. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:13003.
6. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. Journal of Biological Chemistry 2002, 277:2437.
7. Schwarze S., Ho A., Vocero-Akbani A., Dowdy S. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569.
8. Abes R., Arzumanov A., Moulton H., Abes S., Ivanova G., Gait M.J., Iversen P., Lebleu B. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. Journal of Peptide Science 2008, 14:455-460.
9. Gerbal-Chaloin S., Gondeau C., Aldrian-Herrada G., Heitz F., Gauthier-Rouviere C., Divita G. First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling. Biology of the Cell 2007, 99:223-238.
10. Kägi J. Overview of metallothionein. Methods in Enzymology 1991, 205:613.
11. Banerjee D., Onosaka S., Cherian M. Immunohistochemical localization of metallothionein in cell nucleus and cytoplasm of rat liver and kidney. Toxicology 1982, 24:95.
12. Danielson K., Ohi S., Huang P. Immunochemical detection of metallothionein in specific epithelial cells of rat organs. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:2301-2304.
13. Deitel M. Overweight and obesity worldwide now estimated to involve 1.7 billion people. Obesity Surgery 2003, 13:329-330.
14. Flegal K., Carroll M., Ogden C., Johnson C. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723.
15. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
16. Low P., Nickander K., Tritschler H. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes (New York, NY) 1997, 46:38-42.
17. Baynes J. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405.
18. Liang Q., Carlson E., Donthi R., Kralik P., Shen X., Epstein P. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 2002, 51:174.
19. Taylor C. Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. Biometals 2005, 18:305-312.
20. Lee J., Tan C., Lee S., Kim Y., Lee K. Controlled delivery of heat shock protein using an injectable microsphere/hydrogel combination system for the treatment of myocardial infarction. Journal of Controlled Release 2009.
21. Tan C., Ban H., Kim Y., Lee S. The heat shock protein 27 (Hsp27) operates predominantly by blocking the mitochondrial-independent/extrinsic pathway of cellular apoptosis. Molecules and Cells 2009, 27:533-538.
22. Tan C., Kim Y. Antiapoptotic fusion protein delivery systems. Macromolecular Research 2008, 16:481-488.
23. Won Y.W., Kim J.K., Hwang K.C., Choi D., Kim Y.H. Prolongation and enhancement of the anti-apoptotic effects of PTD-Hsp27 fusion proteins using an injectable thermo-reversible gel in a rat myocardial infarction model. Journal of Controlled Release 2010.
24. Dimitriadis G., Boutati E., Lambadiari V., Mitrou P., Maratou E., Brunel P., Raptis S. Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism. European Journal of Clinical Investigation 2004, 34:490-497.
25. Karaskov E., Scott C., Zhang L., Teodoro T., Ravazzola M., Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to ins-1 pancreatic {beta}-cell apoptosis. Endocrinology 2006, 147:3398.
26. Robertson R., Harmon J., Tran P., Tanaka Y., Takahashi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 2003, 52:581.
27. Depre C., Young M., Ying J., Ahuja H., Han Q., Garza N., Davies P., Taegtmeyer H. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. Journal of Molecular and Cellular Cardiology 2000, 32:985-996.
28. Cai L., Li W., Wang G., Guo L., Jiang Y., Kang Y. Hyperglycemia-induced apoptosis in mouse myocardium. Diabetes 2002, 51:1938.
29. Pujals S., Fernández-Carneado J., López-Iglesias C., Kogan M., Giralt E. Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly. BBA-Biomembranes 2006, 1758:264-279.
30. Sugita T., Yoshikawa T., Mukai Y., Yamanada N., Imai S., Nagano K., Yoshida Y., Shibata H., Yoshioka Y., Nakagawa S. Comparative study on transduction and toxicity of protein transduction domains. British Journal of Pharmacology 2008, 153:1143.
31. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicine 2004, 10:310-315.
32. Kothakota S., Azuma T., Reinhard C., Klippel A., Tang J., Chu K., McGarry T., Kirschner M., Koths K., Kwiatkowski D. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997, 278:294.
33. Chandel N., Maltepe E., Goldwasser E., Mathieu C., Simon M., Schumacker P. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:11715.